Well-being of child and family participants in phase 1 pediatric oncology clinical trials

Stacey Crane, Joan Haase, Susan Hickman

Research output: Contribution to journalArticle

Abstract

PROBLEM IDENTIFICATION: Pediatric oncology phase 1 clinical trials (P1Ts) are essential to developing new anticancer therapies; however, they raise complex ethical concerns about balancing the need for this research with the well-being of participating children. The purpose of this integrative review was to synthesize and appraise the evidence of how P1T participation, which begins with consent and ends with the transition off the P1T, can affect the well-being (either positively or negatively) of children with cancer. The Resilience in Individuals and Families Affected by Cancer Framework, which has an outcome of well-being, was used to synthesize findings. LITERATURE SEARCH: Articles on the experiences of child (n = 21) and adult (n = 31) P1T participants were identified through systematic searches. DATA EVALUATION: Articles were evaluated on rigor and relevance to P1T participant experiences as high, medium, or low. SYNTHESIS: Minimal empirical evidence was found regarding the effect of P1T participation on the wellbeing of children with cancer. Adult P1T participant experiences provide insights that could also be important to children's P1T experiences. IMPLICATIONS FOR PRACTICE: To achieve a balanced approach in P1T consent discussions, nurses and healthcare providers who work with children considering participation in a P1T should share the potential effect of participation on participants' well-being.

Original languageEnglish (US)
Pages (from-to)E67-E97
JournalOncology Nursing Forum
Volume45
Issue number5
DOIs
StatePublished - Sep 1 2018

Fingerprint

Child Welfare
Clinical Trials
Pediatrics
Neoplasms
Clinical Trials, Phase I
Health Personnel
Nurses
Research

Keywords

  • Clinical Trials
  • Ethics
  • Pediatric

ASJC Scopus subject areas

  • Oncology(nursing)

Cite this

Well-being of child and family participants in phase 1 pediatric oncology clinical trials. / Crane, Stacey; Haase, Joan; Hickman, Susan.

In: Oncology Nursing Forum, Vol. 45, No. 5, 01.09.2018, p. E67-E97.

Research output: Contribution to journalArticle

@article{d164b838e45b481cbba2e8e4efccfe1e,
title = "Well-being of child and family participants in phase 1 pediatric oncology clinical trials",
abstract = "PROBLEM IDENTIFICATION: Pediatric oncology phase 1 clinical trials (P1Ts) are essential to developing new anticancer therapies; however, they raise complex ethical concerns about balancing the need for this research with the well-being of participating children. The purpose of this integrative review was to synthesize and appraise the evidence of how P1T participation, which begins with consent and ends with the transition off the P1T, can affect the well-being (either positively or negatively) of children with cancer. The Resilience in Individuals and Families Affected by Cancer Framework, which has an outcome of well-being, was used to synthesize findings. LITERATURE SEARCH: Articles on the experiences of child (n = 21) and adult (n = 31) P1T participants were identified through systematic searches. DATA EVALUATION: Articles were evaluated on rigor and relevance to P1T participant experiences as high, medium, or low. SYNTHESIS: Minimal empirical evidence was found regarding the effect of P1T participation on the wellbeing of children with cancer. Adult P1T participant experiences provide insights that could also be important to children's P1T experiences. IMPLICATIONS FOR PRACTICE: To achieve a balanced approach in P1T consent discussions, nurses and healthcare providers who work with children considering participation in a P1T should share the potential effect of participation on participants' well-being.",
keywords = "Clinical Trials, Ethics, Pediatric",
author = "Stacey Crane and Joan Haase and Susan Hickman",
year = "2018",
month = "9",
day = "1",
doi = "10.1188/18.ONF.E67-E97",
language = "English (US)",
volume = "45",
pages = "E67--E97",
journal = "Oncology Nursing Forum",
issn = "1538-0688",
publisher = "Oncology Nursing Society",
number = "5",

}

TY - JOUR

T1 - Well-being of child and family participants in phase 1 pediatric oncology clinical trials

AU - Crane, Stacey

AU - Haase, Joan

AU - Hickman, Susan

PY - 2018/9/1

Y1 - 2018/9/1

N2 - PROBLEM IDENTIFICATION: Pediatric oncology phase 1 clinical trials (P1Ts) are essential to developing new anticancer therapies; however, they raise complex ethical concerns about balancing the need for this research with the well-being of participating children. The purpose of this integrative review was to synthesize and appraise the evidence of how P1T participation, which begins with consent and ends with the transition off the P1T, can affect the well-being (either positively or negatively) of children with cancer. The Resilience in Individuals and Families Affected by Cancer Framework, which has an outcome of well-being, was used to synthesize findings. LITERATURE SEARCH: Articles on the experiences of child (n = 21) and adult (n = 31) P1T participants were identified through systematic searches. DATA EVALUATION: Articles were evaluated on rigor and relevance to P1T participant experiences as high, medium, or low. SYNTHESIS: Minimal empirical evidence was found regarding the effect of P1T participation on the wellbeing of children with cancer. Adult P1T participant experiences provide insights that could also be important to children's P1T experiences. IMPLICATIONS FOR PRACTICE: To achieve a balanced approach in P1T consent discussions, nurses and healthcare providers who work with children considering participation in a P1T should share the potential effect of participation on participants' well-being.

AB - PROBLEM IDENTIFICATION: Pediatric oncology phase 1 clinical trials (P1Ts) are essential to developing new anticancer therapies; however, they raise complex ethical concerns about balancing the need for this research with the well-being of participating children. The purpose of this integrative review was to synthesize and appraise the evidence of how P1T participation, which begins with consent and ends with the transition off the P1T, can affect the well-being (either positively or negatively) of children with cancer. The Resilience in Individuals and Families Affected by Cancer Framework, which has an outcome of well-being, was used to synthesize findings. LITERATURE SEARCH: Articles on the experiences of child (n = 21) and adult (n = 31) P1T participants were identified through systematic searches. DATA EVALUATION: Articles were evaluated on rigor and relevance to P1T participant experiences as high, medium, or low. SYNTHESIS: Minimal empirical evidence was found regarding the effect of P1T participation on the wellbeing of children with cancer. Adult P1T participant experiences provide insights that could also be important to children's P1T experiences. IMPLICATIONS FOR PRACTICE: To achieve a balanced approach in P1T consent discussions, nurses and healthcare providers who work with children considering participation in a P1T should share the potential effect of participation on participants' well-being.

KW - Clinical Trials

KW - Ethics

KW - Pediatric

UR - http://www.scopus.com/inward/record.url?scp=85052103126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052103126&partnerID=8YFLogxK

U2 - 10.1188/18.ONF.E67-E97

DO - 10.1188/18.ONF.E67-E97

M3 - Article

C2 - 30118445

AN - SCOPUS:85052103126

VL - 45

SP - E67-E97

JO - Oncology Nursing Forum

JF - Oncology Nursing Forum

SN - 1538-0688

IS - 5

ER -